deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT02423876

Epidural Anesthesia Within an Enhanced Recovery Pathway in Reducing Pain in Patients Undergoing Gynecologic Surgery

UW14030: Epidural Anesthesia as Part of an Enhanced Recovery Pathway in Gynecologic Surgery

Sponsor: University of Wisconsin, Madison

Conditions Intraoperative Complication Malignant Female Reproductive System Neoplasm Pain
Interventions Epidural analgesia Intraoperative Complication Management and Prevention Pain Therapy
Updated 18 times since 2017 Last updated: Aug 16, 2023 Started: Mar 17, 2015 Primary completion: Jan 3, 2022 Completion: Jan 3, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02423876, this PHASE3 trial focuses on Intraoperative Complication and Malignant Female Reproductive System Neoplasm and remains completed. Sponsored by University of Wisconsin, Madison, it has been updated 18 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshot~Jun 2018 – ~Feb 2019 · 8 months · monthly snapshot~Feb 2019 – ~Jul 2019 · 5 months · monthly snapshot~Jul 2019 – ~Dec 2019 · 5 months · monthly snapshot~Dec 2019 – ~Apr 2020 · 4 months · monthly snapshot~Apr 2020 – ~Jul 2020 · 3 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshot~Jun 2021 – ~Sep 2021 · 3 months · monthly snapshot~Sep 2021 – ~Nov 2021 · 2 months · monthly snapshot~Nov 2021 – ~Jan 2022 · 2 months · monthly snapshot~Jan 2022 – ~Feb 2022 · 31 days · monthly snapshot~Feb 2022 – ~Jan 2023 · 11 months · monthly snapshot~Jan 2023 – ~Oct 2023 · 9 months · monthly snapshot~Oct 2023 – ~Jul 2024 · 9 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Oct 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jan 2023 — Oct 2023 [monthly]

    Completed PHASE3

  5. Feb 2022 — Jan 2023 [monthly]

    Completed PHASE3

    Status: Recruiting → Completed

▶ Show 13 earlier versions

  1. Jan 2022 — Feb 2022 [monthly]

    Recruiting PHASE3

  2. Nov 2021 — Jan 2022 [monthly]

    Recruiting PHASE3

  3. Sep 2021 — Nov 2021 [monthly]

    Recruiting PHASE3

  4. Jun 2021 — Sep 2021 [monthly]

    Recruiting PHASE3

  5. Jan 2021 — Jun 2021 [monthly]

    Recruiting PHASE3

  6. Jul 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

    Status: Suspended → Recruiting

  7. Apr 2020 — Jul 2020 [monthly]

    Suspended PHASE3

    Status: Recruiting → Suspended

  8. Dec 2019 — Apr 2020 [monthly]

    Recruiting PHASE3

  9. Jul 2019 — Dec 2019 [monthly]

    Recruiting PHASE3

  10. Feb 2019 — Jul 2019 [monthly]

    Recruiting PHASE3

  11. Jun 2018 — Feb 2019 [monthly]

    Recruiting PHASE3

  12. Feb 2017 — Jun 2018 [monthly]

    Recruiting PHASE3

  13. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE3

    First recorded

Mar 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Wisconsin, Madison
Data source: University of Wisconsin, Madison

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations